GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (SZSE:300534) » Definitions » EV-to-FCF

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) EV-to-FCF : 25.85 (As of May. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Gansu Longshenrongfa Pharmaceutical Industry Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Gansu Longshenrongfa Pharmaceutical Industry Co's Enterprise Value is ¥2,162 Mil. Gansu Longshenrongfa Pharmaceutical Industry Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥84 Mil. Therefore, Gansu Longshenrongfa Pharmaceutical Industry Co's EV-to-FCF for today is 25.85.

The historical rank and industry rank for Gansu Longshenrongfa Pharmaceutical Industry Co's EV-to-FCF or its related term are showing as below:

SZSE:300534' s EV-to-FCF Range Over the Past 10 Years
Min: -6443.35   Med: 19.4   Max: 2919.43
Current: 25.85

During the past 13 years, the highest EV-to-FCF of Gansu Longshenrongfa Pharmaceutical Industry Co was 2919.43. The lowest was -6443.35. And the median was 19.40.

SZSE:300534's EV-to-FCF is ranked worse than
51.7% of 528 companies
in the Drug Manufacturers industry
Industry Median: 24.695 vs SZSE:300534: 25.85

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Gansu Longshenrongfa Pharmaceutical Industry Co's stock price is ¥7.89. Gansu Longshenrongfa Pharmaceutical Industry Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.210. Therefore, Gansu Longshenrongfa Pharmaceutical Industry Co's PE Ratio for today is 37.57.


Gansu Longshenrongfa Pharmaceutical Industry Co EV-to-FCF Historical Data

The historical data trend for Gansu Longshenrongfa Pharmaceutical Industry Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gansu Longshenrongfa Pharmaceutical Industry Co EV-to-FCF Chart

Gansu Longshenrongfa Pharmaceutical Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,686.72 68.86 86.33 9.81 -98.13

Gansu Longshenrongfa Pharmaceutical Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.12 20.19 16.94 -98.13 29.10

Competitive Comparison of Gansu Longshenrongfa Pharmaceutical Industry Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Gansu Longshenrongfa Pharmaceutical Industry Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gansu Longshenrongfa Pharmaceutical Industry Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gansu Longshenrongfa Pharmaceutical Industry Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Gansu Longshenrongfa Pharmaceutical Industry Co's EV-to-FCF falls into.



Gansu Longshenrongfa Pharmaceutical Industry Co EV-to-FCF Calculation

Gansu Longshenrongfa Pharmaceutical Industry Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2162.341/83.648
=25.85

Gansu Longshenrongfa Pharmaceutical Industry Co's current Enterprise Value is ¥2,162 Mil.
Gansu Longshenrongfa Pharmaceutical Industry Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gansu Longshenrongfa Pharmaceutical Industry Co  (SZSE:300534) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Gansu Longshenrongfa Pharmaceutical Industry Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.89/0.210
=37.57

Gansu Longshenrongfa Pharmaceutical Industry Co's share price for today is ¥7.89.
Gansu Longshenrongfa Pharmaceutical Industry Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.210.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Gansu Longshenrongfa Pharmaceutical Industry Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Gansu Longshenrongfa Pharmaceutical Industry Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) Business Description

Traded in Other Exchanges
N/A
Address
No. 10, Defence Road, Dingyuan Town, Gansu Province, Lanzhou, CHN, 730101
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is mainly engaged in the pharmaceutical business. It is engaged in the research and development of new drugs, traditional Chinese medicine processing and production. Its products portfolio includes Yuan Hu Zhitong Dripping Pills, Qiwei Wenyang Capsule and Xiaoshuan Tongluo Tablets. Its products are used to adjust gas, promote blood circulation, relieve pain, relieve cough, eliminate phlegm, relieve asthma, clear heat, and dispel dampness, among others.
Executives
Chen Yao Wu Executives
Zhang Jin De Director
Zhang Fan Executives
Kong Jian Feng Executives
Yue Qing Xin Supervisors
Kang Yong Hong Executives

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) Headlines

No Headlines